Nonsteroidal antiinflammatory drugs for adjunctive tuberculosis treatment

Journal of Infectious Diseases

Volumn 208, Issue 2, 2013, Pages 185-188

  Ivanyi, Juraj ^a   Zumla, Alimuddin ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

adjunctive treatment; Ibuprofen; non steroidal anti inflammatory drugs; prostaglandin inhibitors; Tuberculosis

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2; GAMMA INTERFERON; IBUPROFEN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 8; LEUKOTRIENE B4; LIPOXIN A; NITROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; ROFECOXIB; TUMOR NECROSIS FACTOR ALPHA;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM ULCER; DRUG SAFETY; DRUG TOLERABILITY; ENZYME INHIBITION; GAMMA DELTA T LYMPHOCYTE; GASTROINTESTINAL HEMORRHAGE; HELPER CELL; HUMAN; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; INTRACRANIAL TUBERCULOMA; MACROPHAGE ACTIVATION; MILITARY TUBERCULOSIS; MORBIDITY; MORTALITY; NONHUMAN; NOTE; PERIPHERAL BLOOD MONONUCLEAR CELL; POPULATION GENETICS; PRIORITY JOURNAL; RELAPSE; RISK REDUCTION; TREATMENT INDICATION; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

ADJUNCTIVE TREATMENT; IBUPROFEN; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PROSTAGLANDIN INHIBITORS; TUBERCULOSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FEMALE; IBUPROFEN; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84879392633     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit153     Document Type: Note

References (27)

1. Zumla A, Raviglione M, Hafner R, von Reyn C. Current concepts - tuberculosis. New Engl J Med 2013; 368:745-55
2. Tomioka H. Adjunctive immunotherapy of mycobacterial infections. Curr Pharm Des 2004; 10:3297-312 (Pubitemid 39276617)
3. Bryk R, Gold B, Venugopal A, et al. Selective killing of nonreplicating mycobacteria. Cell Host Microbe 2008; 3:137-45 (Pubitemid 351325759)
4. Cox JH, Ivanyi J. The role of host factors for the chemotherapy of BCG infection in inbred strains of mice. APMIS 1988; 96:927-32
5. Venkataprasad N, Ledger P, Ivanyi J. The effect of glucosaminylmuramyl dipeptide injection to mice on the course of tuberculous infection and in vitro superoxide anion production. Int Arch Allergy Immunol 1997; 114:23-9 (Pubitemid 27338460)
6. Buccheri S, Reljic R, Caccamo N, et al. Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy. Tuberculosis (Edinb) 2009; 89:91-4
7. Gold B, Pingle M, Brickner SJ, et al. Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials. Proc Natl Acad Sci U S A 2012; 109:16004-11
8. Dutta NK, Mazumdar K, Dastidar SG, Park JH. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. Int J Antimicrob Agents 2007; 30:336-40 (Pubitemid 47371086)
9. Byrne ST, Denkin SM, Zhang Y. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis. J Antimicrob Chemother 2007; 59:313-6 (Pubitemid 47072074)
10. Rangel Moreno J, Estrada Garcia I, et al. The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 2002; 106:257-66
11. Kaul V, Bhattacharya D, Singh Y, et al. An important role of prostanoid receptor EP2 in host resistance to Mycobacterium tuberculosis infection in mice. J Infect Dis 2012; 206:1816-25
12. World Health Organization. Model list of essential medicines 3rd list. Geneva: World Health Organization, 2011. http://www.who. int/medicines/ publications/essentialmedicines/en/. Accessed 19 April 2013.
13. Yu Y, Ricciotti E, Scalia R, et al. Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci TranslMed 2012; 4:132ra54.
14. Ivanyi J. Pathogenic and protective interactions in mycobacterial infections. Clin Immunol and Allerg 1986; 6:127-57
15. Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA. Lung remodeling in pulmonary tuberculosis. J Infect Dis 2005; 192:1201-9
16. Lowe DM, Redford PS, Wilkinson RJ, O'Garra A, Martineau AR. Neutrophils in tuberculosis: friend or foe? Trends Immunol 2012; 33:14-25
17. Tan BH, Meinken C, Bastian M, et al. Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J Immunol 2006; 177:1864-71 (Pubitemid 44092525)
18. Divangahi M, Chen M, Gan H, et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol 2009; 10:899-906
19. A SK, Bansal K, Holla S, Verma-Kumar S, Sharma P, Balaji KN. ESAT-6 induced COX- 2 expression involves coordinated interplay between PI3K and MAPK signaling. Mol Immunol 2012; 49:655-63
20. Peres-Buzalaf C, de Paula L, Frantz FG, et al. Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins. Prostaglandins Leukot Essent Fatty Acids 2011; 85: 75-81
21. Radaeva TV, Nikonenko BV, Mischenko VV, AverbakhMMJr, Apt AS. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice. Tuberculosis (Edinb) 2005; 85: 65-72 (Pubitemid 40431317)
22. Marx GE, Chan ED. Tuberculous meningitis: diagnosis and treatment overview. Tuberc Res Treat 2011; 2011:798764
23. Misra UK, Kalita J, Nair PP. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci 2010; 293:12-7
24. Lawn SD, Meintjes G. Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther 2011; 9:415-30
25. Weberschock TB, Muller SM, Boehncke S, Boehncke WH. Tolerance to coxibs in patients with intolerance to non-steroidal antiinflammatory drugs (NSAIDs): a systematic structured review of the literature. Arch Dermatol Res 2007; 299:169-75 (Pubitemid 46955882)
26. Brennan M. Activation of latent tuberculosis by nonsteroidal anti-inflammatory agents. Can Med Assoc J 1980; 122:400-2 (Pubitemid 10129202)
27. Tomasson HO, Brennan M, Bass MJ. Tuberculosis and nonsteroidal anti-inflammatory drugs. Can Med Assoc J 1984; 130:275-8 (Pubitemid 14186625)